Report Overview:
The global key manufacturers of Sodium Thiosulfate Injection include Pfizer, Hope Pharmaceuticals, Fennec Pharmaceuticals, Chongqing Yaoyou Pharmacy, Tianjin Jinyao Pharmaceutical, Nichi-Iko Pharmaceutical and China Resources Zizhu Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Sodium Thiosulfate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sodium Thiosulfate Injection. This report contains market size and forecasts of Sodium Thiosulfate Injection in global, including the following market information:
Market Value:
The global Sodium Thiosulfate Injection market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the RussiaUkraine War were considered while estimating market sizes.
CAGR of XX%
(2022 – 2029)
By Types:
•10ml : 0.5g
•20ml : 1g
By Applications:
Other Poisoning
Cyanide Poisoning
Key players include:
•Pfizer
•Hope Pharmaceuticals
•Fennec Pharmaceuticals
•Chongqing Yaoyou Pharmacy
•Tianjin Jinyao Pharmaceutical
•Nichi-Iko Pharmaceutical
